Montreal Protocol eliminated. This included a 10-year phase-in for developing countries identified in Article 5 of the treaty. The stated purpose of the treaty is that the signatory states "Recognizing that worldwide emissions of certain substances can significantly deplete and otherwise modify the ozone layer in a manner that is likely to result in adverse effects on human health and the environment. Determined to protect the ozone layer by taking precautionary measures to control equitably total global emissions of substances that deplete it with the ultimate objective of their elimination on the basis of developments in scientific knowledge" "Acknowledging that special provision
Psychoactive Substances Act 2013 will be difficult or impossible. So far, no manufacturing licenses have been applied for. The Act was brought in as a reaction to widespread concerns over the 2005 deregulation, or decriminalisation, of selling psychoactive substances in New Zealand with the introduction of section 62 in the Misuse of Drugs Amendment Act 2005 and the Misuse of Drugs (Restricted Substances) Regulations 2008. These laws made psychoactive substances such as party pills and legal highs available in New Zealand in a relatively new experimental market aimed at decriminalising the production and sale of recreational drugs. Psychoactive Substances Act 2013 The Psychoactive Substances